Company: Glycostem Therapeutics B.V.
Job title: CDO
Maximising Product Stability by Understanding Fundamental Elements of Stability to Advance Cryopreservation Protocols 8:30 am
Benchmarking mechanisms of instability to optimise and standardise cryopreservation protocols, and enable consistent readings between different sites Harnessing quantified measurements of viability and survival with genome profiling, to inform careful comparability studies and yield consistent products Utilising DMSO-free cryopreservation methods and reducing the fill and finish timeframe to improve shelf-life, minimise toxicity and enhance potency…Read more
day: Day Two
Panel Discussion: Equipping the Industry to Overcome the Logistical & Technical Challenges of Scaling Up Allogeneic Manufacturing 3:00 pm
Elucidating the journey from the manufacturing site to patients arm in Europe to allow for smoother transition to clinical investigations Understanding the supply chain system and patient base to build a modular system with clear routes through the supply chain Harnessing intermediate solutions to overcome bottlenecks and improve efficiency of autologous settings before perfecting allogeneic…Read more
day: Day Two